PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 10, 2024SHILAP Revista de lepidopterología5 citationsOpen Access

Thromboembolic prevention in athletes: management of anticoagulation in sports players affected by atrial fibrillation

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Do DOACs provide a safer and more effective anticoagulation strategy compared to coumarin derivatives in athletes with atrial fibrillation?

Population

Athletes with atrial fibrillation (AF) and indications for oral anticoagulant therapy (OAT)

Comparison

Non-vitamin K antagonist direct oral… vs Coumarin derivatives

Design

Review

Authors

SMSimona MinardiLSLuigi SciarraARAntonio Gianluca Robles

Discussion

Loading...

Member takes

Overview

May support considering DOACs for athletes with AF; leaves open confirmation in prospective trials before practice change.

Structured PICO

Do DOACs provide a safer and more effective anticoagulation strategy compared to coumarin derivatives in athletes with atrial fibrillation?

P
Population
Athletes with atrial fibrillation (AF) and indications for oral anticoagulant therapy (OAT)
I
Intervention
Non-vitamin K antagonist direct oral anticoagulants (DOACs)
C
Comparator
Coumarin derivatives
O
Outcome
Efficacy and safety (hemorrhagic and ischemic complications)

DOACs may offer a safer alternative to traditional coumarin derivatives for athletes with atrial fibrillation, potentially allowing for broader participation in sports activities.

Cite This Study

Minardi et al. (2024) studied this question.

synapsesocial.com/papers/69f14cd6c0d8017361865ef8https://doi.org/10.3389/fphar.2024.1384213
View Full Paper
Ask AI
Bookmark
Share